Tirofiban Adjunct Therapy Improves Outcomes in Patients with Inadequate Tenecteplase Response
Trial shows tirofiban improves outcomes for some stroke patients
Intravenous tirofiban significantly improves 90-day functional outcomes for acute ischemic stroke patients failing initial tenecteplase ther…
A new clinical trial suggests that adding tirofiban can improve recovery rates for certain types of stroke patients who do not respond well …
Meta-analysis shows tirofiban improves functional independence but raises intracranial hemorrhage risk in acute ischemic stroke patients
Tirofiban improves stroke recovery but raises bleeding risk
A meta-analysis of 4,210 patients found tirofiban increased functional independence at 90 days compared to conventional management. However,…
A review of 4210 patients finds tirofiban boosts functional independence after stroke but increases bleeding risk.
Meta-analysis shows association between tirofiban and improved functional outcomes in non-LVO acute ischemic stroke
Tirofiban May Help More Stroke Patients Walk and Talk After 90 Days
This meta-analysis of 3,225 patients evaluated the association between tirofiban and conventional antiplatelet therapy for acute ischemic st…
A stroke drug called tirofiban may help more people recover fully after 90 days, especially when used with standard clot-busting treatment.
Tirofiban plus aspirin associated with lower early neurological deterioration in branch atheromatous disease
Early tirofiban plus aspirin linked to fewer early neurological declines in branch atheromatous disease patients
A retrospective single-center cohort study in patients with acute branch atheromatous disease found early tirofiban plus aspirin was associa…
Early tirofiban plus aspirin reduced early neurological decline from 55.1% to 10.1% in branch atheromatous disease patients compared to stan…